Medibank Private Ltd (OTCPK:MDBPF)

$ 2.01 0 (0%) Market Cap: 6.92 Bil Enterprise Value: 6.49 Bil PE Ratio: 16.46 PB Ratio: 4.36 GF Score: 75/100

Medibank Private Ltd Annual Shareholders Meeting Transcript
Nov 22, 2023
Full Year 2023 Medibank Private Ltd Earnings Call Transcript
Aug 23, 2023

$1.9 (-7.32%)

Earnings
Half Year 2023 Medibank Private Ltd Earnings Call Transcript
Feb 22, 2023

$1.93

Earnings
Medibank Private Ltd Annual Shareholders Meeting Transcript
Nov 15, 2022
Medibank Private Ltd Cybercrime and Trading Update Transcript
Oct 25, 2022
Medibank Private Ltd Update On Medibank Cyber Incident Transcript
Oct 16, 2022
Full Year 2022 Medibank Private Ltd Earnings Call Transcript
Aug 17, 2022

$2.1

Earnings
Half Year 2022 Medibank Private Ltd Earnings Call Transcript
Feb 24, 2022

$2.46

Earnings
Medibank Private Ltd Annual Shareholders Meeting Transcript
Nov 17, 2021
Full Year 2021 Medibank Private Ltd Earnings Call Transcript
Aug 24, 2021

$1.9

Earnings
Half Year 2021 Medibank Private Ltd Earnings Call Transcript
Feb 23, 2021

$1.9

Earnings
Medibank Private Ltd Annual Shareholders Meeting Transcript
Nov 11, 2020
Full Year 2020 Medibank Private Ltd Earnings Call Transcript
Aug 19, 2020

$1.9

Earnings
Half Year 2020 Medibank Private Ltd Earnings Call Transcript
Feb 19, 2020

$1.9

Earnings
Medibank Private Ltd Annual Shareholders Meeting Transcript
Nov 13, 2019
Full Year 2019 Medibank Private Ltd Earnings Call Transcript
Aug 21, 2019

$1.9

Earnings
Half Year 2019 Medibank Private Ltd Earnings Call Transcript
Feb 14, 2019

$1.9

Earnings

Medibank Private Ltd Cybercrime and Trading Update Transcript

Oct 25, 2022 / 11:00PM GMT

Release Date Price: $2.1

Transcript

David Koczkar

Medibank Private Limited - CEO, MD & Director

Good morning all, and thank you for joining us at such short notice. I'll begin by acknowledging the traditional owners and custodians of country throughout Australia and their connections to land, sea and community.

I join you today from Naarm, the home of the Wurundjeri Woiwurrung Peoples. I pay my respects to their elders past, present and emerging, and I extend my respect to all elders of the lands on which we work and live.

I'm joined today by Medibank's executive team, including our Group Executive of Technology and Operations, John Goodall and our Group Executive CFO and Group Strategy, Mark Rogers.

As you know, on Friday, we entered a voluntary trading suspension as we continued to investigate the impact and implications of the cybercrime announced on 13 October.

This morning, we provided an update to our investigation, and I will take a few moments to run through what we've now learned through our investigation and what we are doing in response, before Mark provides an update of how this will

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.